The Oncology Institute, Inc. (TOIIW)
USD 0.02
(-17.27%)
USD 0.02
(-17.27%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 136.59 Million USD | -8.35% |
| 2022 | 124.1 Million USD | 43.13% |
| 2021 | 86.7 Million USD | 92.36% |
| 2020 | 45.07 Million USD | 38.33% |
| 2019 | 32.58 Million USD | 51.62% |
| 2018 | 21.49 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 27.87 Million USD | 3.3% |
| 2024 Q1 | 28.45 Million USD | 1.3% |
| 2023 Q4 | 28.08 Million USD | -6.07% |
| 2023 Q1 | 30.09 Million USD | -2.16% |
| 2023 FY | 113.73 Million USD | -8.35% |
| 2023 Q2 | 30.05 Million USD | -0.15% |
| 2023 Q3 | 29.9 Million USD | -0.51% |
| 2022 Q4 | 30.76 Million USD | -7.05% |
| 2022 FY | 124.1 Million USD | 43.13% |
| 2022 Q3 | 33.09 Million USD | 12.4% |
| 2022 Q2 | 29.44 Million USD | -4.37% |
| 2022 Q1 | 30.79 Million USD | -37.37% |
| 2021 Q1 | 11.95 Million USD | -73.19% |
| 2021 Q4 | 49.16 Million USD | 262.03% |
| 2021 Q3 | 13.58 Million USD | 13.11% |
| 2021 Q2 | 12 Million USD | 0.43% |
| 2021 FY | 86.7 Million USD | 92.36% |
| 2020 Q2 | 9.34 Million USD | -45.28% |
| 2020 Q1 | 17.08 Million USD | 0.0% |
| 2020 FY | 45.07 Million USD | 38.33% |
| 2020 Q4 | 44.59 Million USD | 22367.79% |
| 2020 Q3 | 198.48 Thousand USD | -97.88% |
| 2019 FY | 32.58 Million USD | 51.62% |
| 2018 FY | 21.49 Million USD | 0.0% |
| 2018 Q4 | 9.59 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 22.397% |
| Addus HomeCare Corporation | 248.92 Million USD | 45.127% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -15.44% |
| Amedisys, Inc. | 834.47 Million USD | 83.632% |
| American Oncology Network, Inc. | 83.97 Million USD | -62.657% |
| Astrana Health, Inc. | 112.59 Million USD | -21.31% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 76.745% |
| IMAC Holdings, Inc. | 5.02 Million USD | -2617.079% |
| biote Corp. | 98.82 Million USD | -38.214% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -287.983% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 59.552% |
| COMPASS Pathways plc | 136.91 Million USD | 0.24% |
| DocGo Inc. | 180.32 Million USD | 24.254% |
| The Ensign Group, Inc. | 335.39 Million USD | 59.274% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 27.765% |
| InnovAge Holding Corp. | 558.25 Million USD | 75.532% |
| Assure Holdings Corp. | 15.43 Million USD | -784.714% |
| The Joint Corp. | 109.22 Million USD | -25.057% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 72.194% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -648.767% |
| ModivCare Inc. | 586.89 Million USD | 76.727% |
| NewGenIvf Group Limited | 1.63 Million USD | -8231.041% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -911.345% |
| Option Care Health, Inc. | 666.62 Million USD | 79.51% |
| P3 Health Partners Inc. | 199.56 Million USD | 31.556% |
| P3 Health Partners Inc. | 199.56 Million USD | 31.556% |
| The Pennant Group, Inc. | 88.99 Million USD | -53.482% |
| Surgery Partners, Inc. | 319.5 Million USD | 57.249% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -3076.905% |
| Talkspace, Inc. | 97.58 Million USD | -39.966% |
| Talkspace, Inc. | 97.58 Million USD | -39.966% |
| The Oncology Institute, Inc. | 136.59 Million USD | 0.0% |